Herein, we evaluated the feasibility of placing patients in a tilted head position as part of routine clinical practice for fractionated stereotactic radiotherapy (FSRT) of intracranial tumors using helical tomotherapy (HT), by assessing its dosimetric benefit and setup accuracy. We reviewed treatment plans of four cases that were to receive FSRT for brain lesions in normal and head-tilted positions. These patients underwent two computed tomography (CT) scans: first in the normal supine position and then in the supine position with the head tilted at a 458 angle. Two separate HT plans for each position were generated in these four patients, using the same planning parameters. Plans were compared for target conformity and dose homogeneity. Maximum and average doses to critical organs, including normal brain, brain stem, optic chiasm, optic nerves, and the eyes, were considered. To evaluate setup accuracy, patient movement during treatment was assessed by post-treatment megavoltage CT scans. Both HT plans achieved similar conformal and homogeneous dose coverage to the target. Head-tilted HT delivered lower average and maximum doses to critical organs in the cases where the tumor was located on the same plane with critical organs, particularly when they were not directly attached. Placement in the head-tilted position without a mouthpiece allowed for increased patient movement during treatment, while use of a mouthpiece reduced patient movement to even less than that observed for normal setup in the supine position. This pilot study showed that placement in a tilted head position for FSRT of intracranial tumors using HT may be of clinical use, but depends on the tumor location.
Introduction
Helical tomotherapy (HT) (1) is the combined modality of image-guided radiotherapy and intensity-modulated radiotherapy (IMRT), which can maximize the irradiation dose to the targeted gross tumor while reducing incidental doses to nearby organs at risk (OARs) (2) . HT offers several unique features including thousands of targeted beamlets, 3608 delivery, and megavoltage computed tomography (MVCT) image guidance (3, 4) . Thus, HT holds some advantages for irradiating intracranial tumors by: 1) providing accurate radiotherapy using
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non-invasive patient immobilization devices, 2) enabling high-dose or hypofractionated irradiation of the target tumor, and 3) improving target volume coverage with target conformity and dose homogeneity, regardless of the shape of the target volume. These advantages improve local control and survival rates.
However, HT is strictly limited to coplanar delivery, due to a fixed couch angle relative to the gantry. This limitation poses a significant geometric problem when targeting certain tumor volumes because critical structures often lie parallel to the target in the axial plane (5) . In such cases, fractionated stereotactic radiotherapy (FSRT) using linear acceleratorbased radiotherapy or radiosurgery using a CyberKnife is favored, because these modalities can deliver non-coplanar beams. One recent study that investigated the feasibility of non-coplanar HT for lung stereotactic body radiotherapy (SBRT) using rotating patient computed tomography (CT) images to mimic couch rotation reported that non-coplanar HT arcs significantly improve critical organ sparing in SBRT for lung cancer without affecting the target volume dose coverage (6) .
Application of FSRT for treating brain tumors is limited because many OARs, including the optic chiasm, bilateral optic nerves, eyes, brain stem, normal brain, and inner ears, are often close to the gross tumor. Therefore, it is hypothesized that non-coplanar HT applications for FSRT of brain tumors may help overcome this limitation. Although HT cannot deliver non-coplanar beams in one treatment plan, we can easily generate a non-coplanar condition by tilting the patient's head at a 458 angle using a patient setup/immobilization device. Accordingly, our pilot study was designed to evaluate the clinical feasibility of placing patients in a headtilted position for FSRT of intracranial tumors by comparing its potential dosimetric benefit and setup accuracy between HT plans for normal and head-tilted positions.
Materials and Methods

Patient Selection
We reviewed the treatment plans of four cases that received FSRT to irradiate brain lesions in normal and head-tilted positions. These patients received HT treatment between July 2009 and June 2010 at Gangnam Severance Hospital, Yonsei University Health System, Seoul, Korea. Case 1 presented with brain metastases in the right parietal lobe that had metastasized from lung cancer; Case 2 exhibited brain metastases in the right cerebellum that originated from breast cancer; Case 3 involved three brain metastases in the right cerebellum, left parietal lobe, and right occipital lobe that originated from breast cancer; and Case 4 consisted of low-grade glioma at the left frontal lobe and basal ganglia. The median age of the patients was 51 years (range 33 to 72 years).
Radiotherapy
First, all patients underwent two CT scans: the first in the normal supine position typically used and the second in a supine position with the head tilted at a 458 angle using an Axis Variable Baseplate (CIVCO Medical Solutions, Kalona, IA). For both setups, a thermoplastic mask was used to immobilize patients. A mouthpiece (Precise BiteTM; CIVCO Medical Solutions) attached to the thermoplastic mask was used for Case 4 to enhance the accuracy and stability of patient setup, as this patient was scheduled to receive 25 fractionated treatments. The patient's ability to tolerate the tilting of their head 458 was thoroughly checked during the CT scans. Patient setup is illustrated in Figure 1 . A physician researcher delineated all of the targets and normal organs. The researcher tried not to allow for target volume variation between two positions. HT plans were generated for each patient using these two setup positions, with the option for either complete or directional block of the eyes, lens, and optic nerves, depending on the target tumor location. Targets were defined following the description by Manning et al. (7) . The gross tumor volume and clinical target volume (CTV) were considered equivalent, and the planning target volume (PTV) was expanded from CTV with a 2 mm margin in all directions to account for any setup inaccuracies.
The total dose and fraction size were determined for each case. For each HT, a total prescription dose of 8 Gy in 1 fraction, 15 Gy in 5 fractions, and 55 Gy in 25 fractions were planned for cases 1 and 2, case 3, and case 4, respectively. A field width of 1.05 cm and nominal modulation factors of 2.5 to 3.0 were used for three metastases cases (Cases 1 to 3), and a field width of 2.5 cm and a nominal modulation factor of 2.5 was used for Case 4, which was a low-grade glioma. Pitch, the distance of couch travel per gantry rotation relative to field width, was set at 0.3 for Cases 1 to 3 and at 0.25 for Case 4. Dose calculation grid size was set as the normal grid setting for the tomotherapy planning system, corresponding to 3 3 3 mm 2 . Identical planning parameters of field width, modulation factor, pitch, and dose calculation grid were applied to optimize HT plans for both positions in each patient. These plans were performed by the same dosimetrist with the intention of achieving similar target coverage. Treatment characteristics are summarized in Table I .
Plan Evaluation
Plans were evaluated for dose conformity and homogeneity. Dose conformity was assessed according to the conformation number (CN) proposed by van't Riet et al. (8) . The CN is calculated as: CN 5 (V T, pres /V T ) 3 (V T, pres /V pres ), where V T, pres is the target volume receiving a dose equal to or greater than the prescription dose, V T is the target volume, and V pres is the volume receiving a dose equal to or greater than the prescription dose. A CN closer to 1 indicates optimal conformation. In the present study, a CN above 0.60 was considered to comply with the treatment plan. A homogeneity index (HI) was also calculated to evaluate the dose homogeneity within the target volume, as recommended by the International Commission on Radiation Units and Measurements (9) . The HI was calculated from the formula: HI 5 (D 2 -D 98 )/D median , where D 98 is the radiation dose received by at least 98% of the target volume, D 2 is the dose received by at least 2% of the target volume, and D median is the median dose to the target volume. The D 98 and D 2 values are considered to be the minimum and maximum doses, respectively. A lower HI value indicates a more homogeneous dose administered to the target volume. An HI value of zero represents an absolutely homogeneous dose within the target.
For the plan evaluation of OARs, maximum and mean radiation doses to critical organs including normal brain, brain stem, optic chiasm, optic nerves, and the eyes were considered. The integral dose to normal brain was also evaluated. Integral dose was calculated using the equation: integral dose 5 average dose to normal brain 3 average brain density (1.05 g/cm 3 ) 3 volume of normal brain.
Intrafractional Movement
Intrafractional movement was compared between the two setups by evaluating translational and rotational MVCT shift after HT treatment. A pre-treatment MVCT scan was generated after patient setup for each treatment session, and at the end of treatment, another MVCT scan was acquired to evaluate patient movement during treatment. This MVCT was registered with the planning CT, so that the translational offsets in the lateral (X), longitudinal (Y), and vertical (Z) directions as well as the rotational shift (Roll) were obtained. Total displacement (R) was also calculated using the equation:
2 . A mouthpiece was used to stabilize the tilted position of the head.
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Patient movement during treatment in the normal position, head-tilted position, and head-tilted position with mouthpiece fixation were evaluated by one-way analysis of variance (ANOVA). Statistical analyses were conducted using SPSS (version 18; SPSS, Chicago, IL). All P-values less than 0.05 were considered indicative of statistically significant differences.
Results
Plan Evaluation
Treatment Planning: A single dosimetrist performed all treatment planning using identical planning parameters of field width, pitch, and modulation factor for each patient. Table II lists these values for all cases.
Dose to Critical Organs: Even though average and maximum doses to critical OARs were not significantly different between these two HT approaches, head-tilted HT showed less high dose exposure to critical organs, depending on the tumor location. For Case 1, the radiation dose to critical organs did not differ between the two HT approaches. For Case 2, the head-tilted approach allowed for delivery of greater doses to all evaluated critical organs, except the eyes. Nevertheless, an increase of only 1.5 Gy greater than the maximum dose was delivered to the optic chiasm, which was within the tolerable range. For Case 3, treatment in the headtilted position allowed for delivery of reduced radiation doses to all critical OARs, including the average dose and the maximum dose. Dose-volume histograms for Case 3 are presented in Figure 3 . For Case 4, the maximum dose to the left eye and the average and maximum doses to the left optic nerve were increased when using the head-tilted position due to the location of the target on the left side. However, other critical organs including normal brain, brain stem, optic chiasm, for the normal approach, 1.54 6 1.918 with the head-tilting/ no mouthpiece arrangement, and 0.55 6 0.538 when using the head-tilting setup with mouthpiece (p 5 0.197). Case 3 showed maximum movement in both translational and rotational directions. This was because this patient had the longest treatment time (990.98 seconds) due to the existence of three different lesions that required treatment.
Discussion
HT is a radiation modality capable of planning a high conformity of target irradiation from a rotational gantry. However, non-coplanar beams are not an option with conventional normal HT due to the mechanical design of the closed gantry and fixed couch angle. This limitation presents critical geometric problems in cases of intracranial tumors that are located parallel to adjacent OARs and in the same axial plane. Especially with cranial tumors, such as high-grade glioma, OARs such as the optic chiasm, optic nerve, and eyes are incidentally irradiated when using coplanar techniques. Thus, noncoplanar radiation delivery is thought to be able to reduce right eye, and right optic nerve received a lower radiation dose from treatment in the head-tilted position compared to that in the normal position. The integral dose to normal brain for treatment in the head-tilted position increased in Case 2, whose tumor was located in the cerebellum on the same plane with the eyes; however, integral doses in the other three cases were reduced. These results are summarized in Table II .
Intrafractional Movement
Intrafractional movement was calculated for each setup position: 1) normal position (n 5 7); 2) head-tilted position without mouthpiece (n 5 7); and 3) head-tilted position with mouthpiece (n 5 11). The averages and standard deviations of intrafractional movement calculated for each setup position are summarized in Table III . In general, setup in the head-tilted position without a mouthpiece allowed for greater patient movement during treatment, while use of a mouthpiece with the head-tilted reduced movement to a level that irradiated doses to OARs when treating intracranial tumors. Unlike HT, some IMRT studies have shown that non-coplanar IMRT techniques reduce the radiation dose received by OARs adjacent to tumors in certain malignancy types (10, 11) . A recent study also reported that non-coplanar IMRT and volumetric-modulated arc therapy (VMAT) techniques spared the contralateral optic structures significantly better than coplanar IMRT and VMAT for treating frontotemporal high-grade glioma (12) . However, studies examining the feasibility of using a non-coplanar HT approach are still lacking. One recent study investigated the feasibility of using noncoplanar HT for lung cancer SBRT (6) . These researchers produced oblique helical arcs by rotating the patient's CT images, and planned for a patient with hypothetical tumors in both lungs using 10, 20, and 30 degrees of couch yaw. Their study reported that non-coplanar HT arcs significantly reduce the irradiated dose to critical organs, such as the normal lung, chest, and heart in lung SBRT without compromising the planning target volume dose coverage. Also, previous studies have evaluated the oncologic outcome and toxicity of HT for treating intracranial tumors (13, 14) . Nevertheless, our study is the first to investigate the feasibility of performing HT after placing patients in a tilted head position to mimic non-coplanar approaches for minimizing incidental OAR irradiation during radiotherapy against intracranial tumors.
We selected cases with intracranial tumors at diverse locations, including the frontal, parietal, occipital, and temporal lobes, to compensate for limitations with having a small experimental sample size. Therein, we hypothesized that head-tilted HT would provide better OAR-sparing effects in cases in which the tumor was located on the same plane as OARs. Dose to the eyes in most cases was reduced by headtilted HT with the use of directional or complete block in the HT planning. In Case 1, the target volume was located in the right parietal lobe and was quite distant from critical organs. Thus, only small portions of OARs were located on the same plane with the target volume, and as a result, head-tilted HT offered little dosimetric benefit in this case. In contrast, the entire target volume in Case 2 was located directly behind the brain stem in the right cerebellum. In this case, although head-tilted HT delivered increased radiation doses to critical organs, except for both eyes, the doses received by the critical organs were within tolerable ranges. Of particular note, head-tilted HT reduced the incidental irradiation doses delivered to all critical organs in Case 3, in which target volumes were in the right cerebellum, left parietal lobe, and right occipital lobe on the same plane with critical organs; however, these were not directly attached. In Case 4, the target volume in the left frontal lobe and basal ganglia was right behind the left optic nerve, and as a result, the dose to left optic nerve was increased by head-tilted HT. However, doses to all other OARs, including the brain stem, were decreased by head-tilted HT, despite the fact that the target volume of this case was located anterior to brain stem. Accordingly, we discerned that HT in a tilted head position might provide better dosimetric benefit when the target volume is located anteriorly to OARs, compared posteriorly, on the same plane, since a greater portion of anteriorly located target volumes can be moved into a different plane by tilting of the head 458 than posteriorly located target volumes. Therefore, the dosimetric benefit could differ from case to case depending on differences in the relative position between target volumes and OARs; deeper examination, especially for optimal tilting angle, of a greater number of cases is needed.
Since FSRT using a high precision RT modality delivers higher radiation doses more accurately, intrafractional movement can cause severe radiation-induced toxicity to structures near the target tumor, resulting in inadequate treatment. Many studies have investigated the intrafractional movement of patients treated with high precision RT modalities, including HT (15) (16) (17) (18) . Therefore, we compared patient intrafractional movement using different HT setup positions. Our results showed that use of a mouthpiece reduces intrafractional movement caused by tilting a patient's head to a 458 angle. Such movement using this approach was even less than that observed using a conventional normal setup position. We determined that additional patient head immobilization with the addition of a mouthpiece improves the clinical utility and applicability of head-tilted HT when irradiating intracranial tumors.
Due to the limitations of this pilot study, our results should be interpreted with caution. Since this study was a retrospective study with a small number of patients, data were inhomogeneous, and could have affected our results. Even so, this study is the first to suggest the clinical feasibility of tomotherapy treatment in selective cases of intracranial tumors with the patient in a tilted head position as an effort to overcome the geometric limitations of the tomotherapy machine itself. However, prudence is required in the clinical implementation of this head-tilting position because intrafractional movement could induce uncertainties in radiation dose delivery. To minimize these uncertainties, immobilization with a mouthpiece should be applied, and a physician should thoroughly review the dosimetric results of the head-tilted HT plan. In addition, careful assessment of intrafractional motion is recommended.
Conclusions
We investigated the potential dosimetric benefit and setup accuracy of using placing patients in a tilted head position for FSRT of intracranial tumors using HT. Although a small number of patients were enrolled, head-tilted HT plans showed reduced incidental irradiation doses to critical organs in cases where the tumor was located on the same plane as
